2025 first_quarter Filing
Q1Income
$10K
Filed
May 6, 2025
Lobbying Activities
Health IssuesView all
Development of Amicidins to serve as a countermeasure/therapeutic intervention for Sepsis
Contacted:Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (1)
DANIEL FARACI